IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: a potential anti-angiogenic therapeutic target (2019)
- Authors:
- USP affiliated authors: GIORDANO, RICARDO JOSÉ - IQ ; BASSÈRES, DANIELA SANCHEZ - IQ
- Unidade: IQ
- DOI: 10.1016/j.lungcan.2019.02.027
- Subjects: NEOPLASIAS PULMONARES; ANTINEOPLÁSICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Lung Cancer
- ISSN: 0169-5002
- Volume/Número/Paginação/Ano: v. 130, p. 169-178, 2019
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
LOBO, Tatiana Correa Carneiro et al. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: a potential anti-angiogenic therapeutic target. Lung Cancer, v. 130, p. 169-178, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.lungcan.2019.02.027. Acesso em: 24 abr. 2024. -
APA
Lobo, T. C. C., Scalabrini, L. C., Magalhães, L. da S., Cardeal, L. B., Rodrigues, F. S., Santos, E. O. dos, et al. (2019). IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: a potential anti-angiogenic therapeutic target. Lung Cancer, 130, 169-178. doi:10.1016/j.lungcan.2019.02.027 -
NLM
Lobo TCC, Scalabrini LC, Magalhães L da S, Cardeal LB, Rodrigues FS, Santos EO dos, Baldwin AS, Levantini E, Giordano RJ, Bassères DS. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: a potential anti-angiogenic therapeutic target [Internet]. Lung Cancer. 2019 ; 130 169-178.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.lungcan.2019.02.027 -
Vancouver
Lobo TCC, Scalabrini LC, Magalhães L da S, Cardeal LB, Rodrigues FS, Santos EO dos, Baldwin AS, Levantini E, Giordano RJ, Bassères DS. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: a potential anti-angiogenic therapeutic target [Internet]. Lung Cancer. 2019 ; 130 169-178.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.lungcan.2019.02.027 - Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer
- IKKβ is a potential anti-angiogenic therapeutic target in KRAS-induced lung cancer
- Aurora kinases: potential therapeutic targets in K-Ras-induced lung cancer
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression
- Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells
- Exploring IKKβ as an anti-metastatic therapeutic target in KRAS-induced lung cancer
- Targeting Aurora A kinase activity in lung cancer initiating cells driven by oncogenic KRAS
- IKKβ inhibition suppresses sphere formation and self renewal of lung cancer initiating cells
- Aurora kinase targeting in lung cancer reduces KRAS-induced transformation
- IKKβ kinase promotes stemness, migration, and invasion in KRAS-driven lung adenocarcinoma cells
Informações sobre o DOI: 10.1016/j.lungcan.2019.02.027 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
